A mutation in the integrin αIIb subunit that selectively inhibits αIIbβ3 receptor function
Kim B. Perkins, Joseph C. Loftus
Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Summary
The αIIb and αv integrins have been shown to play a significantrole in a variety of disease processes. αIIbβ3 is a platelet-specificfibrinogen receptor that is critical for thrombosis and hemostasis.Determination of the basis of ligand recognition by αIIbβ3is essential for modulation of platelet function. To identify αIIbresidues involved in αIIbβ3 ligand binding function, cells expressinga constitutively active variant of αIIbβ3 were randomlymutagenized and selected for loss of αIIbβ3 ligand binding function.One mutant isolated in this manner contained a singleamino acid substitution at position 96 in αIIb (Ser96→Leu).Cells expressing this αIIb mutant did not bind the ligand mimetic antibody PAC1 or adhere to fibrinogen. In addition, themutant receptor did not bind to an RGD affinity matrix.Substitution of conserved serine residues at position 1 in βstrand A of all seven repeats of αIIb similarly inhibited ligandbinding to αIIbβ3. αIIb S96 maps to the central cavity of the β-propellerfold of the a IIb subunit immediately adjacent to astructurally important sequence at the center of the α and βsubunit interface. In contrast, substitution of the analogous residuesin a αv or a α4 did not disrupt the ligand binding function of αvβ3 or α4β1. These data support a potential unique structuralor mechanistic role for this residue in αIIbβ3 receptor function. DOI
http://dx.doi.org/10.1160/TH03-03-0157